View Past PerformanceRedcentric バランスシートの健全性財務の健全性 基準チェック /36Redcentricの総株主資本は£54.3M 、総負債は£42.3Mで、負債比率は77.9%となります。総資産と総負債はそれぞれ£179.9Mと£125.6Mです。 Redcentricの EBIT は£9.8Mで、利息カバレッジ比率2.7です。現金および短期投資は£4.1Mです。主要情報77.89%負債資本比率UK£42.29m負債インタレスト・カバレッジ・レシオ2.7x現金UK£4.06mエクイティUK£54.30m負債合計UK£125.64m総資産UK£179.94m財務の健全性に関する最新情報更新なしすべての更新を表示Recent updatesお知らせ • 7hRedcentric plc, Annual General Meeting, Oct 20, 2026Redcentric plc, Annual General Meeting, Oct 20, 2026.お知らせ • 8h+ 2 more updatesRedcentric plc (AIM:RCN) announces an Equity Buyback for 56,250,000 shares, representing 35.31% for £90 million.Redcentric plc (AIM:RCN) announces a share repurchase program. Under the program, the company will repurchase up to 56,250,000 ordinary shares, representing 35.30% for £90 million. The shares will be repurchased at a price of £1.60 per share. Any ordinary shares repurchased by the company will be cancelled. The program will be funded from the company’s existing distributable reserves and the additional reserves expected to be created as a result of the capital reduction. The program is subject to approval from shareholders at the general meeting. As of June 11, 2026, the company had 159,321,733 shares in issue, of which 496 Ordinary Shares held in treasury.Board Change • Jun 02High number of new and inexperienced directorsThere are 5 new directors who have joined the board in the last 3 years. The company's board is composed of: 5 new directors. 1 experienced director. No highly experienced directors. Senior Independent Non-Executive Director AJ Aubrey is the most experienced director on the board, commencing their role in 2022. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of board continuity. Lack of experienced directors.Board Change • May 20High number of new and inexperienced directorsThere are 5 new directors who have joined the board in the last 3 years. The company's board is composed of: 5 new directors. 1 experienced director. No highly experienced directors. Senior Independent Non-Executive Director AJ Aubrey is the most experienced director on the board, commencing their role in 2022. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of board continuity. Lack of experienced directors.お知らせ • Nov 05Redcentric plc to Report First Half, 2026 Results on Dec 10, 2025Redcentric plc announced that they will report first half, 2026 results on Dec 10, 2025お知らせ • Sep 25Redcentric plc, Annual General Meeting, Oct 20, 2025Redcentric plc, Annual General Meeting, Oct 20, 2025. Location: the offices of cavendish capital markets ltd, 1 bartholomew close, ec1a 7bl, london United Kingdomお知らせ • Sep 24Redcentric plc Provides Revenue Guidance for the Fiscal Year 2026Redcentric plc provided revenue guidance for the fiscal year 2026. For the year, the company announces stable revenue expectations.お知らせ • Aug 22Redcentric plc Confirms Advanced Stages of Discussions Concerning the Potential Sale of its Business Unit, Redcentric Data Centres LimitedThe Board of Directors of Redcentric plc (AIM:RCN) noted the recent press speculation regarding its business unit, Redcentric Data Centres Limited. Redcentric plc confirmed that it is in the advanced stages of discussions concerning the potential sale of this business unit. However, there can be no certainty that a transaction will occur and further updates will be provided as appropriate.お知らせ • Aug 19Redcentric plc Announces Appointment of Tony Ratcliffe as Chief Financial Officer, Effective 19 August 2025Redcentric plc announced the appointment of Tony Ratcliffe as Chief Financial Officer with immediate effect. Tony has over 25 years' senior financial management experience with fast growing technology and service companies, including on AIM and Nasdaq. This experience extends across a number of high growth sectors, including healthcare, software and materials science. Most recently, Tony was CFO of SourceBio International, a healthcare technology group, where he led its AIM IPO and a successful restructuring which contributed to a fourfold increase in revenues and significant increase in profitability over a two-year period. In prior CFO roles, Tony has acquired varied operational, transactional, and strategic experience and driven significant growth, both organically and via M&A, with an ultimate focus on creating value for shareholders. Tony qualified as a Chartered Accountant with KPMG and has an MBA from Heriot-Watt University, Edinburgh.財務状況分析短期負債: RCNLの 短期資産 ( £123.4M ) が 短期負債 ( £78.9M ) を超えています。長期負債: RCNLの短期資産 ( £123.4M ) が 長期負債 ( £46.7M ) を上回っています。デット・ツー・エクイティの歴史と分析負債レベル: RCNLの 純負債対資本比率 ( 70.4% ) は 高い と見なされます。負債の削減: RCNLの負債対資本比率は、過去 5 年間で4%から77.9%に増加しました。債務返済能力: RCNLの負債は 営業キャッシュフロー によって 十分にカバー されています ( 54.7% )。インタレストカバレッジ: RCNLの負債に対する 利息支払い は EBIT ( 2.7 x coverage) によって 十分にカバーされていません。貸借対照表健全な企業の発掘7D1Y7D1Y7D1YSoftware 業界の健全な企業。View Dividend企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/06/19 05:24終値2026/06/16 00:00収益2025/09/30年間収益2025/03/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレークこのレポートを生成するために使用した分析モデルの詳細は、当社の Github ページ でご覧いただけます。また、レポートの使い方に関する ガイド や YouTube の チュートリアル もご用意しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋Redcentric plc 1 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。4 アナリスト機関Steven RobertsonCanaccord GenuityAndrew Murray DarleyCavendishPhilip CarseProgressive Equity Research1 その他のアナリストを表示
お知らせ • 7hRedcentric plc, Annual General Meeting, Oct 20, 2026Redcentric plc, Annual General Meeting, Oct 20, 2026.
お知らせ • 8h+ 2 more updatesRedcentric plc (AIM:RCN) announces an Equity Buyback for 56,250,000 shares, representing 35.31% for £90 million.Redcentric plc (AIM:RCN) announces a share repurchase program. Under the program, the company will repurchase up to 56,250,000 ordinary shares, representing 35.30% for £90 million. The shares will be repurchased at a price of £1.60 per share. Any ordinary shares repurchased by the company will be cancelled. The program will be funded from the company’s existing distributable reserves and the additional reserves expected to be created as a result of the capital reduction. The program is subject to approval from shareholders at the general meeting. As of June 11, 2026, the company had 159,321,733 shares in issue, of which 496 Ordinary Shares held in treasury.
Board Change • Jun 02High number of new and inexperienced directorsThere are 5 new directors who have joined the board in the last 3 years. The company's board is composed of: 5 new directors. 1 experienced director. No highly experienced directors. Senior Independent Non-Executive Director AJ Aubrey is the most experienced director on the board, commencing their role in 2022. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of board continuity. Lack of experienced directors.
Board Change • May 20High number of new and inexperienced directorsThere are 5 new directors who have joined the board in the last 3 years. The company's board is composed of: 5 new directors. 1 experienced director. No highly experienced directors. Senior Independent Non-Executive Director AJ Aubrey is the most experienced director on the board, commencing their role in 2022. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of board continuity. Lack of experienced directors.
お知らせ • Nov 05Redcentric plc to Report First Half, 2026 Results on Dec 10, 2025Redcentric plc announced that they will report first half, 2026 results on Dec 10, 2025
お知らせ • Sep 25Redcentric plc, Annual General Meeting, Oct 20, 2025Redcentric plc, Annual General Meeting, Oct 20, 2025. Location: the offices of cavendish capital markets ltd, 1 bartholomew close, ec1a 7bl, london United Kingdom
お知らせ • Sep 24Redcentric plc Provides Revenue Guidance for the Fiscal Year 2026Redcentric plc provided revenue guidance for the fiscal year 2026. For the year, the company announces stable revenue expectations.
お知らせ • Aug 22Redcentric plc Confirms Advanced Stages of Discussions Concerning the Potential Sale of its Business Unit, Redcentric Data Centres LimitedThe Board of Directors of Redcentric plc (AIM:RCN) noted the recent press speculation regarding its business unit, Redcentric Data Centres Limited. Redcentric plc confirmed that it is in the advanced stages of discussions concerning the potential sale of this business unit. However, there can be no certainty that a transaction will occur and further updates will be provided as appropriate.
お知らせ • Aug 19Redcentric plc Announces Appointment of Tony Ratcliffe as Chief Financial Officer, Effective 19 August 2025Redcentric plc announced the appointment of Tony Ratcliffe as Chief Financial Officer with immediate effect. Tony has over 25 years' senior financial management experience with fast growing technology and service companies, including on AIM and Nasdaq. This experience extends across a number of high growth sectors, including healthcare, software and materials science. Most recently, Tony was CFO of SourceBio International, a healthcare technology group, where he led its AIM IPO and a successful restructuring which contributed to a fourfold increase in revenues and significant increase in profitability over a two-year period. In prior CFO roles, Tony has acquired varied operational, transactional, and strategic experience and driven significant growth, both organically and via M&A, with an ultimate focus on creating value for shareholders. Tony qualified as a Chartered Accountant with KPMG and has an MBA from Heriot-Watt University, Edinburgh.